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The presence of an autocrine adrenergic and cholinergic intra/intercellular signal transduction network in the
human epidermis contributes significantly to homeostatic and compensatory responses regulating vital
functions in keratinocytes and melanocytes. The ligands produced control autocrine and paracrine loops to
initiate responses through cognate receptors expressed within the same or adjacent cells. The epidermal
adrenergic signal controls calcium homeostasis, cell growth, differentiation, motility, and pigmentation via the
b2 and a1 adrenoceptors. The cholinergic system is highly complex comprising both nicotinic and muscarinic
receptors with multiple subtypes and this system plays an important role in keratinocyte cell cycle progression,
differentiation, directional migration, adhesion, and apoptotic secretion. Moreover, lymphocytes also express
adrenergic and cholinergic receptors. Both types of signal transduction receptors are coupled to classical
intracellular second messenger pathways, including cAMP-, cGMP-, and calcium-mediated downstream
responses. To date, it has been recognized that several dermatoses such as psoriasis, atopic dermatitis, Mal
de Meleda, vitiligo, palmoplantar pustulosis, and pemphigus may be mediated, in part, by the non-neuronal
adrenergic/cholinergic systems. A detailed understanding of the physiology and pathophysiology of the
adrenergic/cholinergic network in the skin could offer the development of specific drugs for novel treatment
modalities.
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During the past two decades, the
discovery of signaling systems within
the epidermis that utilize classical
ligand–receptor modules prototypic of
the nervous system have radically
changed our view of cellular commu-
nication within this skin compartment.
This review provides a current update
on the expression, functions, and
pathologies of the epidermal adrener-
gic and cholinergic receptor systems.
These dynamic intercellular communi-
cation pathways of the epidermis are
remarkable in that both signaling sys-
tems function as well-established and
extensively characterized counterparts
of the nervous system. Not surprisingly,
perhaps, these systems have been
replicated and modified for locally
mediated signaling crosstalk within
the skin and the nervous system. In
turn, they have been adapted to serve
unique roles in the biology of epider-
mal keratinocytes (KCs) and melano-
cytes (MCs).
The intricacies regulating how the
cell interprets the ligand–receptor acti-
vating (or inhibitory) signal(s) and the
crosstalk between the second messen-
ger pathways that determine the out-
come or ‘‘translate’’ downstream
response(s) are only just beginning to
be understood. To lesser or greater
extents, the intracellular messenger
pathways are linked to each other, thus
forming a network, which can be
exquisitely regulated. The richly ex-
pressed receptor pathways on the cell
surface of epidermal KCs and MCs lead
to a coordinated cellular response.
Therefore, our understanding of the
intricate biochemistry and biology that
underpins the cutaneous adrenergic and
cholinergic systems for signal transduc-
tion has grown dramatically over the
past few years, and the renewing
novelty of discovery surrounding these
hitherto ‘‘unconventional’’ receptor sys-
tems continues to fascinate, challenge,
and reward both the neophyte and
seasoned investigators in the field.
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THE NON-NEURONAL ADRENERGIC
SYSTEM OF THE EPIDERMIS
Autocrine catecholamine synthesis/degra-
dation and signal transduction is present
in human epidermal KCs
Nowadays, it is established that the
human epidermis holds the full capa-
city for autocrine catecholamine synth-
esis from the essential amino acid
L-phenylalanine. The first step includes
turnover from this amino acid to
L-tyrosine by the enzyme phenylala-
nine hydroxylase (EC 1.14.16.1, PAH)
in the presence of iron, molecular
oxygen, and the cofactor/electron do-
nor (6R)-L-erythro-5,6,7,8-tetrahydro-
biopterin (6BH4), followed by the
rate-limiting step via tyrosine hydroxy-
lase (EC 1.14.16.2, TH), again con-
trolled by 6BH4 (Nagatsu et al., 1964).
Here it is of interest that both KCs and
MCs only express TH isoenzyme I,
whereas isoenzymes II, III, and IV are
absent (Marles et al., 2003). The
biosynthetic pathway for catechola-
mines is shown in Figure 1.
Increased enzyme activities of TH
and phenylethanolamine-N-methyl-
transferase (EC 2.1.1.28), the last enzy-
matic step in catecholamine synthesis,
confirmed upregulated de novo epi-
nephrine synthesis in undifferentiated
epidermal KCs compared to differen-
tiated KCs under in vitro conditions
(Schallreuter et al., 1995, 1997). These
observations are in agreement with
considerably higher epinephrine levels
in undifferentiated cells (ie 268 fmol/
mg protein) compared to 13 fmol/mg
protein in differentiated cells (Schall-
reuter et al., 1997). Moreover, epider-
mal transcription, translation, and
function of both catecholamine-de-
grading enzymes, that is, catechola-
mine-O-methyltransferase (EC 2.1.1.6)
and monoamine oxidase A (EC 1.4.3.4)
have been documented (Le Poole et al.,
1994; Schallreuter et al., 1996b).
As mentioned above, catecholamine
synthesis requires the essential cofactor
6BH4, and both KCs and MCs have
indeed the machinery for its de novo
synthesis/recycling and regulation
(Figure 2) (Schallreuter et al., 1994b).
In situ immunofluorescence labeling
showed strong protein expression for
pterin 4a-carbinolamine dehydratase
(EC 4.2.1.96) in basal KCs with marked
reduction in suprabasal layers (Schall-
reuter et al., 2001). These results are in
agreement with enhanced enzyme ac-
tivities in the basal layer, although
activities are significantly reduced
upon differentiation (Schallreuter
et al., 1994b). Hence, basal KCs super-
sede the production and recycling of
the cofactor compared to differentiated
cells (Schallreuter et al., 1994c, 1997).
Epinephrine synthesis coincides with
the expression of high-affinity b2-adreno-
ceptors (7.500 receptors/cell) in un-
differentiated KCs, whereas receptor
numbers fall significantly (2.500 recep-
tors/cell) after differentiation (Schallreu-
ter et al., 1993).
The epidermal b2-adrenergic signal-
ing response yields a major intracellu-
lar increase in the second messenger
cAMP, which in turn increases intra-
cellular calcium concentrations via acti-
vated protein kinase C (PKC) (Koizumi
et al., 1991, 1997; Schallreuter et al.,
1992; Yasui et al., 1992). cAMP repre-
sents an important feedback loop for
both the synthesis of epinephrine and
the expression of b2-adrenoceptors.
Moreover, the promoters of the TH
and the b2-adrenoceptor genes contain
a cAMP response element binding
domain, thus controlling transcription
for the hormone as well as b2-adreno-
ceptor density (Kuroda et al., 1993).
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Figure 1. Biosynthesis of catecholamines. L-Tyrosine is produced from L-phenylalanine by PAH using O2
as substrate and 6BH4 as cofactor. L-Tyrosine is oxidized by TH to L-dopa, which is converted to
dopamine by L-aromatic amino acid decarboxylase. Oxidation by dopamine-b-hydroxylase leads
to norepinephrine. Finally, phenylethanolamine-N-methyltransferase catalyzes the formation of
epinephrine from norepinephrine in the presence of S-adenosyl-L-methionine.
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Figure 2. De novo synthesis, recycling, and regulation of 6BH4 biosynthesis. 6BH4 is synthesized de
novo from GTP by the rate-limiting enzyme GTP-cyclohydrolase I (GTP-CH I) followed by two further
enzymatic steps (6-pyruvoyl tetrahydropterin synthase (PTPS) and sepiapterin reductase (SR)). The
essential cofactor 6BH4 serves for the conversion of L-phenylalanine to L-tyrosine by PAH, leading to the
formation of 4a-OH-carbinolamine (4a-OH-BH4) and the non-enzymatic production of 7BH4. 4a-OH-
BH4 continues through the recycling program to quinonoid-dihydrobiopterin via 4a-pterincarbinolamine
dehydratase (PCD), which is then fully reduced to 6BH4 by the NADH (nicotinamide adenine
dinucleotide (reduced form))-dependent dihydropteridine reductase (DHPR). The de novo synthesis/
recycling of 6BH4 is tightly controlled by the GTP-cyclohydrolase I feedback regulatory protein (GFRP),
where the binding of L-phenylalanine to GFRP upregulates GTP-CH I whereas 6BH4 binding to the
protein downregulates the de novo production of 6BH4 (Harada et al., 1993; Milstien et al., 1996).
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Interestingly, Zhou et al. (1997) demon-
strated in cardiac myocytes that cAMP
opens the voltage-gated calcium chan-
nel followed by an intracellular calcium
increase after stimulation of b2-adreno-
ceptors. Recently, a similar mechanism
has been proposed for epidermal KCs
(Denda et al., 2003b). An epidermal
calcium gradient has been established
by Menon et al. (1985), who demon-
strated low concentrations in the basal
layer with increasing concentrations
toward the stratum corneum. It has
been shown that both epidermal pro-
liferation and differentiation are under
tight control by calcium (Boyce and
Ham, 1983). Moreover, b2-adrenocep-
tor densities in KCs depend on intra-
and extracellular calcium concentra-
tions. Enhanced skin barrier recovery
has been observed after
topical application of the specific
b2-adrenoceptor antagonist ICI-118551
and the b1/b2-antagonist clenbuterol,
whereas there was no effect
on the repair in acetone-induced
hyperproliferation after application of
specific b2-agonist/antagonist (Denda
et al., 2003a). This observation
implicated for the first time the b2-
adrenoceptor signal in skin barrier
function.
b-Adrenergic receptor activation in-
hibits KC migration via a cyclic adeno-
sine monophosphate-independent
mechanism (Chen et al., 2002). Iso-
proterenol, a b-adrenergic receptor-
selective agonist, inhibited cell migra-
tion stimulated by either epidermal
growth factor or extracellular Ca2þ in
a concentration-dependent manner.
This was prevented by pretreatment of
the cells with the b-adrenergic recep-
tor-selective antagonist timolol. The
b-adrenergic receptor-induced inhibi-
tion of KC migration could be mediated
through inhibition of the extracellular
signal-regulated kinase mitogen-acti-
vated protein kinase signaling in a
cyclic adenosine monophosphate-in-
dependent manner. Recently, it has
been demonstrated that b2-adrenergic
receptor activation inhibited KC migra-
tion by decreasing the phosphoryla-
tion of the extracellular signal-related
kinase via the pathway involving acti-
vation of the serine/threonine phospha-
tase PP2A (Pullar et al., 2003).
Taken together, the presence of the
catecholamine/b2-adrenoceptor signal-
ing pathway in KCs is one important
regulator in the differentiation process
and in control of epidermal barrier
homeostasis via the voltage-gated cal-
cium channel.
The presence of the adrenergic
signal transduction system has also
been recognized in outer and inner
root sheath KCs of the hair follicle.
However, the precise understanding of
its function needs to be addressed in
more detail in future research.
Autocrine catecholamine biosynthesis
and a1- and b2-adrenoceptors are present
in human epidermal MCs
Human MCs express all of the mRNAs
and all of the enzymes for epinephrine
synthesis. However, although these
cells are able to translate phenyletha-
nolamine-N-methyltransferase in situ,
enzyme activities were not detectable
(Marles et al., 2003; Gillbro et al.,
2004). Hence, MCs appear to be
noradrenergic cells. Moreover, these
cells hold also catecholamine degrada-
tion by catecholamine-O-methyltrans-
ferase and monoamine oxidase A and
they have the machinery for de novo
synthesis/recycling and regulation of
6BH4 (Le Poole et al., 1994; Schallreu-
ter et al., 1994b, 1996b). The rate-
limiting step for epidermal synthesis of
epinephrine in KCs and norepinephrine
synthesis in MCs is controlled by TH
isoenzyme I (Marles et al., 2003). The
presence of TH in MCs has been
questioned recently by Kagedal et al.
(2004). These authors found only very
low mRNA levels under their experi-
mental conditions in neonatal and
immortalized MCs as well as melano-
ma cell lines. Marles et al. (2003)
readdressed the issue using reverse
transcription-PCR (RT-PCR) and HPLC
analysis as well as enzyme activities.
Interestingly, the amelanotic melano-
ma cell line FM3 did not express any
TH isoform I, whereas tyrosinase
mRNA was present. However, melano-
ma cell lines with different pigmenta-
tion capacities (FM55 and FM94)
revealed a strong expression of this
isoform. L-Dopa formation by TH was
confirmed by the method of Reichardt
as described by Marles et al. (2003).
The expression of TH in association
with formation of pigment as shown in
FM55 and FM94 cells together with the
absence of TH in amelanotic cells
(FM3) supports the involvement of this
enzyme in melanogenesis, as proposed
earlier by Marles et al. (2003). How-
ever, the presence of TH in the cytosol
holds also the rate-limiting step for
norepinephrine synthesis in pigment
cells. Therefore, the question how
catecholamine synthesis is controlled
in amelanotic cells arises. This issue
needs to be addressed in future re-
search.
After exposure to 200 nmol norepi-
nephrine for 24 hours, MCs expressed
4.278 a1-adrenoceptors/cell, indicating
transcriptional activity induced by this
hormone (Schallreuter et al., 1996a).
Very recently, it has been recognized
that MCs also express low-affinity
b2-adrenoceptors at a similar cell den-
sity, that is, 4.230 receptors/cell (Gill-
bro et al., 2004). Using the specific
b2-adrenoceptor agonist salbutamol, it
was shown that MCs express only
b2-adrenoceptors, whereas b1-adreno-
ceptors were absent (Gillbro et al.,
2004). The presence of a functioning
b2-adrenoceptor signal in MCs high-
lights the symbiotic relationship be-
tween KCs and MCs in the basal layer
of the epidermis, as only these KCs
synthesize and release the majority of
epinephrine formed, which is the pre-
ferred ligand for the b2-adrenoceptor.
Catecholamine induced melanogenesis
via the IP3/diacylglycerol/PKC and the
b2-adrenoceptor/cAMP cascade in MCs
Both the a1-adrenoceptor and the
b2-adrenoceptor can exercise a major
influence on melanogenesis in MCs.
The norepinephrine/a1-adrenoceptor
signal initiates the IP3/diacylglycerol/
PKC cascade, leading to increased MC
dendricity and melanin biosynthesis
(Peacocke et al., 1988; Gordon and
Gilchrest, 1989; Gilchrest et al., 1993;
Park et al., 1999, 2004). In this context,
it has been shown that PKC-b activates
tyrosinase 2.5-fold by phosphorylating
serine residues in its cytoplasmic do-
main (Park et al., 1999, 2004). Further-
more, the release of calcium from
intracellular stores by IP3 causes an
increase of this ion in the cytosol,
1950 Journal of Investigative Dermatology (2006), Volume 126
SA Grando et al.
Adrenergic and Cholinergic Control in the Biology of Epidermis
which could foster cellular L-phenyl-
alanine uptake followed by its intracel-
lular turnover to L-tyrosine by PAH,
finally providing sufficient levels of this
substrate for melanogenesis (Schallreu-
ter and Wood, 1999).
Besides the presence of the IP3/
diacylglycerol/PKC cascade and the
a-melanocyte-stimulating hormone
(a-MSH)/melanocortin-1 receptor/cAMP
signal in MCs, the discovery of a
functioning epinephrine/b2-adrenocep-
tor/cAMP signal in these cells provides
a new source for regulation of melano-
genesis (Gillbro et al., 2004). Here it is
of interest that the specific b2-adreno-
ceptor agonist salbutamol enhances
cAMP levels as well as receptor den-
sities in association with increased
melanogenesis (Gillbro et al., 2004).
In this context, it has been proposed
that cAMP together with cAMP re-
sponse element binds to the promoter
of the microphthalmia associated tran-
scription factor gene to enhance its
transcription (Gaggioli et al., 2003).
Microphthalmia associated transcrip-
tion factor is also a transcription factor
controlling the expression of tyrosinase
(Widlund and Fisher, 2003). In addi-
tion, cAMP levels regulate phosphati-
dylinositol-3-kinase activation and
Rho-Rac downstream responses to alter
actin organization, which is important
for dendricity of MCs. Thus, both
nuclear and cytoplasmic functions of
the MC in pigmentation are regulated
through cAMP activity. Hence, epider-
mal catecholamines together with the
a1- and b2-adrenoceptor signal can
profoundly influence the pigmentation
process.
These new results rule out that the
proposed a-MSH/melanocortin-1 re-
ceptor signal in human MCs is the only
signal in control of the cAMP/melano-
genesis cascade (Im et al., 1998; Abdel-
Malek, 2001). Future work is needed to
gain more detailed knowledge,
which in turn can be applied toward
beneficial interventions in pigmentary
disturbances.
Catecholamines and b2-adrenoceptor sti-
mulation can induce immunosuppressive
effects
Catecholamines inhibit the antigen-
presenting capability of epidermal
Langerhans cells, which can respond
to the adrenergic stimuli via a1- and b2-
adrenoceptors (Maestroni, 2000; Seif-
fert et al., 2002; Maestroni and Mazzo-
la, 2003). Lymphocytes constitutively
express a2- and b2-adrenoceptors sup-
porting the involvement of the cate-
cholamines as immunomodulators
(Schauenstein et al., 2000). Recently,
it has been shown that the b2-adreno-
ceptor agonists salbutamol and terbu-
talin have the capacity to inhibit the
expression of CD40 and CD14, as well
as intercellular adhesion molecule 1 in
lipopolysaccharide-stimulated periph-
eral blood lymphocytes (Kuroki et al.,
2004). Moreover, these agonists could
also inhibit the production of tumor
necrosis factor-a (TNF-a) in these cells.
These effects were abrogated by the
selective b2-antagonist butoxamine.
The same authors showed also inhibi-
tion of T-cell proliferation via b2-adre-
noceptor stimulation. This observation
is well in tune with elevated catecho-
lamine and cortisol levels described
after general stress (Carrasco and
Van de Kar, 2003). Here it is of interest
that repeated social stress leads to
neutrophilia, lymphopenia, and mono-
cytosis in peripheral blood cells (Engler
et al., 2004). Furthermore, a significant
reduction of natural killer cells has
been shown after acute psychological
and physical stress via b-adrenergic
stimulation (Kanemi et al., 2005).
Taking into consideration that the
human epidermis holds the full ma-
chinery for catecholamine synthesis
together with the a1- and b2-adreno-
ceptor signals, it is tempting to spec-
ulate that this system significantly
contributes in loco to the epidermal
immune response. As corticosteroids
are major enhancers of b2-adrenocep-
tor transcription, a tight relationship
between both hormonal systems is
apparent (Stryer, 1988).
Catecholamines in vitiligo – what do we
know?
Perturbed 6BH4 synthesis/recycling/
regulation influences catecholamine
synthesis and degradation. An over-
production of the cofactor 6BH4 in
association with elevated GTP-cyclo-
hydrolase I (EC 3.5.4.16) enzyme activ-
ities has been demonstrated in both the
pigmented and repigmented epidermis
of patients with vitiligo (Schallreuter
et al., 1994b, c, 1999). Interestingly,
the rate-limiting step for 6BH4 de novo
synthesis via GTP-cyclohydrolase I is
influenced by multiple signals includ-
ing TNF-a, IL-2, IFNg, and H2O2
(Ziegler et al., 1990; Werner et al.,
1991; Shimizu et al., 2003). Elevated
levels of TNF-a, IL-2, IFNg, and H2O2
were indeed documented in vitiligo
(Schallreuter et al., 1994c; Moretti
et al., 2002). Moreover, epidermal
PAH activities are significantly lower
in vitiligo compared to controls (Schall-
reuter et al., 1994b). One possible
consequence of elevated 6BH4 levels
and decreased PAH activities are low
tyrosine levels. Therefore, this scenario
provides an ideal situation for activa-
tion of TH in association with increased
catecholamine synthesis (Naoi et al.,
1993). This mechanism would be in
agreement with significantly elevated
norepinephrine levels and decreased
phenylethanolamine-N-methyltransfer-
ase enzyme activities in the skin and
plasma of patients with active vitiligo
(Schallreuter et al., 1994c; Salzer and
Schallreuter, 1995). It is therefore not
surprising that the degradation via
catecholamine-O-methyltransferase
and monoamine oxidase A activities is
induced (Le Poole et al., 1994; Schall-
reuter et al., 1996b). Elevated levels of
catecholamine metabolites in the urine
of patients with acute progressive dis-
ease were reported by several groups
(Morrone et al., 1992; Cucchi et al.,
2003), supporting the above-described
cascade.
Increased b2-adrenoceptor densities in
vitiliginous KCs and impaired calcium
uptake/efflux. Increased expression of
b2-adrenoceptors has been observed in
differentiating epidermal KCs estab-
lished from the depigmented skin of
patients with vitiligo (Schallreuter
et al., 1993). In addition, a defective
calcium uptake/efflux was shown in
both KCs and MCs (Schallreuter and
Pittelkow, 1988). Increased epidermal
b2-adrenoceptor densities in vitiligo
could be explained by the presence of
high biopterin levels in this compart-
ment (Schallreuter et al., 1994b). Here
it is noteworthy that 6-biopterin is the
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oxidation product of 6BH4 and a
significant increase in b2-adrenoceptor
density has indeed been recognized in
normal human KCs after exposure to
6-biopterin (107 M) for 48 hours
(Schallreuter et al., 1995; Gillbro,
2002. Importantly, 6-biopterin can be
reduced back to 6BH4 by intracellular
thioredoxin reductase and by gluta-
thione reductase as well as by reduced
glutathione (Schallreuter et al., 1994a;
Schallreuter and Wood, unpublished
results, 2005). These results emphasize
the importance of the 6BH4-redox
balance in control of b2-adrenoceptor
transcription and density.
H2O2 and its influence on 6BH4/
catecholamine homeostasis. To date,
there are multiple lines of in vitro and
in vivo evidence for the involvement of
oxidative stress by H2O2 in the patho-
genesis of vitiligo. This initiates a
cascade of metabolic and signaling
events in the epidermis but also in the
vascular system of affected individuals
including perturbed de novo synthesis/
recycling and regulation of 6BH4,
calcium and catecholamine homeosta-
sis (reviewed by Schallreuter, 2005).
The removal of H2O2 from the epider-
mis by a narrow-band UVB311 nm-acti-
vated pseudocatalase (a.k.a. PC-KUS)
contributes to the recovery of multiple
H2O2-induced effects in association
with arrest of the active depigmentation
process and restoration of the skin color
(Schallreuter et al., 1999, 2004). This
approach offered a plethora of new
insights into H2O2-controlled mechan-
isms, including DNA damage, altera-
tion of protein structures, peptides such
as a- and b-MSH, enzyme activities,
regulation of cofactor 6BH4, p53 ex-
pression, and transcriptional activity
via dimerisation cofactor hepatocyte
nuclear factor (DCoH)/hepatocyte nu-
clear factor-a (Aronoff, 1965; Vile,
1997; Moore et al., 1999; Schallreuter
et al., 2001, 2003, 2004; Anderson
et al., 2003; Hasse et al., 2004, 2005;
Rokos et al., 2004; Schallreuter, 2005).
However, at the present time, the
autoimmune hypothesis is still the most
favorite view in the pathogenesis of
vitiligo (Le Poole et al., 1996). In the
light of increased norepinephrine levels
in the plasma as well as in the
epidermis of affected individuals, it is
tempting to invoke a direct role for
catecholamines in the postulated im-
mune response (Salzer and Schallreu-
ter, 1995). However, the epidermal
upregulation of b2-adrenoceptors by
6-biopterin/6BH4 in patients with viti-
ligo could also offer a direct role for this
cofactor as an important immunomo-
dulator (Schallreuter et al., 1993,
1995). This hypothesis is in part sup-
ported by the observation that
b2-adrenoceptor antagonists can trigger
both the onset and the progression of
vitiligo (Schallreuter, 1995).
Atopic eczema and b2-adrenoceptor
signaling – an old concept in a new light
Early and recent reports have impli-
cated the involvement of the b2-adre-
noceptor and recently chromosome
5q3133 has been identified to play a
role in asthma and atopic eczema
(Szentivanyi, 1968; Postma et al.,
1995). It is of interest that this region
of chromosome 5 contains the b2-
adrenoceptor as well as steroid receptor
genes. Although the majority of work in
this region has focused on the IL-4
cluster (Howard et al., 1982; Hudak
et al., 1987), there is also evidence for
functional polymorphisms in the b2
adrenoceptor gene in asthma and ato-
pic dermatitis (Postma and Kerstjens,
1998). Further study of these genes may
yield important information regarding
the pathogenesis of atopic dermatitis.
Moreover, several point mutations in
the b2-adrenoceptor gene have been
shown in mild-to-moderate asthma
(Gln27-Glu27) and in severe disease
(Arg16-Gly16) (Reihsaus et al., 1993;
Hall et al., 1995). The first indication for
b2-adrenoceptor dysfunction in atopic
eczema was reported by Pochet et al.
(1980), who found decreased b2-adre-
noceptor binding in peripheral blood
lymphocytes of these patients. In 1997,
a point mutation in the b2-adrenoceptor
gene was detected in nine unrelated
patients with atopic eczema showing a
substitution of Ala119-Asp119 in trans-
membrane helix 3 of the receptor only
two turns away from the epinephrine
binding site at Asp113 (Schallreuter,
1997, 1999; Schallreuter et al., 1997;
Ro¨cken et al., 1998). The identified
mutation was caused by a substitution
in the codon GCC to GAC. Conse-
quently, the entire b2-adrenoceptor
gene was sequenced in three affected
individuals following the procedure of
Kobilka et al. (1987), and the result
confirmed several silent mutations as
reported previously. Additional compu-
ter analysis of the receptor structure
supported that the mutation Ala119-
Asp119 caused a dramatic change in the
orientation of transmembrane helix 3
(Schallreuter, 1997; Schallreuter et al.,
1997). The functional consequences of
this mutation yielded indeed impaired
antagonist binding to b2-adrenoceptors
on both undifferentiated KCs and per-
ipheral blood lymphocytes in four
patients tested. The results indicated
competition for antagonist binding to
Asp113 and Asp119 affecting the KD six-
fold (Schallreuter, 1997; Schallreuter
et al., 1997; Ro¨cken et al., 1998).
Moreover, there was a significant
decrease in receptor densities on both
cell types (P¼ 0.0001).
Epidermal undifferentiated KCs es-
tablished from one child affected by
atopic eczema yielded only very low
receptor densities compared to healthy
controls. Moreover, the results demon-
strated a 50% response to catechola-
mine stimulation in the asymptomatic
mother compared to the healthy con-
trol (Schallreuter, 1997b; Schallreuter
et al., 1997). Taken together, all of the
above results implicate possible invol-
vement of catecholamines and signal
transduction via b2-adrenoceptors in
atopic eczema if not in the entire
atopic triad.
Currently, investigation of atopic
eczema is focused on autoimmunity
being the key element in the pathogen-
esis of the disease (Ro¨cken et al., 1998).
The evidence noted above suggests that
further studies regarding the role of the
epidermal catecholamine signal in
modulating the immune response may
yield important new clues regarding
the pathogenesis of atopic dermatitis.
THE NON-NEURONAL CHOLINER-
GIC SYSTEM OF THE EPIDERMIS
Biological significance of epidermal
acetylcholine
Acetylcholine (ACh) is produced by
practically all types of living cells, and
its concentration is remarkably high in
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the surface epithelia (Klapproth et al.,
1997). The amount of free ACh is a
function of its synthesis by choline
acetyltransferase (ChAT) and hydrolysis
by acetylcholinesterase (AChE). ACh
and related compounds elicit biologic
effects through binding to the nicotinic
and the muscarinic classes of ACh
receptors, nAChRs and mAChRs. The
heteromeric nAChR channels mediat-
ing the influx of Naþ and Ca2þ and
efflux of Kþ in non-muscle cells can be
composed of a2, a3, a4, a5, a6, b2, b3,
and b4 subunits, for example,
a3b2(b4)7a5, and a9 subunit can form
a heteromeric channel with a10 (Elgoy-
hen et al., 2001). The homomeric
channels are comprised by several 27,
28, or 29 subunits. The mAChR family
is comprised of five, M1–M5, receptor
subtypes preferentially coupled to dis-
tinct signal transduction pathways via
specific G proteins.
ACh has emerged as a candidate for
a regulatory role in numerous biologic
processes that are intimately connected
to each other, including proliferation,
differentiation, apoptosis, adhesion,
and migration. Environmental and en-
docrine stimuli affect ACh metabolism
and signaling. For example, both light
(Tretyn and Tretyn, 1990) and tempera-
ture modulate the intensity of ACh
synthesis (Yasuyama et al., 1996) and
degradation (Sanchez-Yague et al.,
1990), as well as ACh receptor function
(Hayashi et al., 1988). Moreover,
retinoids induce activity of the ACh-
synthesizing enzyme (Berse and Blusz-
tajn, 1995), increase nAChR numbers
(Halvorsen et al., 1996), and can also
alter expression and activity of
mAChRs (Baumgartner et al., 1993),
upregulating M3 (Louie, 1996). Both
androgens and estrogens stimulate ACh
synthesis (Gibbs, 1996; Gibbs et al.,
1997) but exhibit reciprocal effects on
ACh receptors (Bleisch and Harrelson,
1989; Batra, 1990). Glucocorticoster-
oids regulate ACh synthesis by modify-
ing the amount/activity of cholinergic
enzymes, which may vary depending
on the cell type (Kaufman et al., 1988;
Reinheimer et al., 1998), and also
upregulate nAChRs (Braun et al.,
1993) and mAChRs (Marquardt et al.,
1982). Growth factors produced by KCs
can also influence ACh metabolism
and signaling. Nerve growth factor
can modulate expression/activity of
the cholinergic enzymes and ACh
receptor signaling (Biagioni et al.,
2000). An intriguing interdependency
of KC proliferation on cutaneous in-
nervation in general (Hsieh and Lin,
1999) and on cholinergic neurotrans-
mitters in particular (Haegerstrand
et al., 1989), and, vice versa, nerve
growth on KC-derived growth factor
(Takei et al., 1988), may be explained
by ectodermal relationships between
the stratified epithelium and the neural
tissues.
The KC ACh may excite cutaneous
nociceptors and modulate noxious sti-
muli (Biagioni et al., 2000) via synapse-
like connections between nerve end-
ings and epidermal cells (Chateau and
Misery, 2004). Indeed, unmyelinated
epidermal c-fibers have been shown to
express both the mAChR and nAChR
classes on the axonal membrane
(Haberberger and Bodenbenner, 2000;
Lang et al., 2003). Thus, endocrine
hormones and environmental stimuli
modify structure/function of the cuta-
neous cholinergic network, and the
latter can use ACh as a common cyto/
neurotransmitter to send signals about
environmental changes to central ner-
vous system.
Cholinergic control of KCs
The KC ACh axis. The high-affinity
choline transporter 1 was found both
in the epidermis and cells of the
internal root sheath of the hair follicle
(Haberberger et al., 2002). The ChAT
activity in homogenates of KCs is 20
pmol ACh/mg protein/min (Grando
et al., 1993). KCs not only synthesize
ACh but also secrete it. A single KC
synthesizes a mean of 21017 mol
and releases 71019 mol of ACh per
minute (Grando et al., 1993). The AChE
activity of KCs is about 1.13 U/mg
protein (Grando et al., 1993). The
results of PCR experiments confirmed
that human KCs contain mRNA of
ChAT, and both forms of AChE, that
is, the asymmetric membrane anchored
and the globular secreted forms
(Nguyen et al., 2001). Both ChAT and
true AChE were demonstrated in
the epidermis and cultured cells by
immunostaining (Grando et al., 1993;
Johansson and Wang, 1993; Klapproth
et al., 1997). ChAT was found distri-
buted equally throughout the entire
epidermis. The degrading enzyme
AChE was seen predominantly in the
basal cell layer. This distribution of
ChAT and AChE suggested that free
ACh is accumulated in the uppermost
epidermal compartment. Staining of
the epidermis with an antibody specific
to ACh confirmed the above assump-
tion (Nguyen et al., 2001).
RT-PCR amplified a3, a5, a7, a9,
a10, b2, and b4 subunits of the nAChR
in human epidermal and oral KCs
(Grando et al., 1995, 1996; Nguyen
et al., 2000a, b; Sgard et al., 2002).
Recently, these findings have been
independently verified by Kurzen
et al. (2004), who also reported the
presence of the ‘‘muscle’’ b1 nAChR
mRNA and protein in human KCs. Early
studies identified M1, M3, M4, and M5
mAChR subtypes in human epidermal
KCs, whereas oral KCs were found to
express M2, M3, M4, and M5 receptors
(Ndoye et al., 1998; Arredondo et al.,
2003a). Although it has been known
that rat epidermal KCs also express the
M2 subtype (Haberberger and Boden-
benner, 2000), the presence of M2 in
human epidermal KCs was demon-
strated only recently (Elwary et al.,
2004; Kurzen et al., 2004).
In the epidermis, the repertoire of
cholinergic enzymes and receptors
changes with cell maturation, so that
at each stage of their development KCs
respond to ACh via different combina-
tions of ACh receptors. Basal KCs
respond to ACh predominantly via
a3b2(b4)7a5 nAChRs and the M2 and
M3 mAChRs; prickle KCs have more a5-
containing a3 nAChRs, and also express
a9 nAChR as well as M4 and M5
mAChRs; granular KCs posses mainly
a7 nAChR and M1 mAChR. A highly
variable expression of the ACh recep-
tors in epidermis, especially the hetero-
meric channels with contribution from
the a3 nAChR subunit, has also been
noticed (Kurzen, 2004). Putative influ-
encing factors include age, atopic dis-
position, smoking habits, and minimal
trauma (Kurzen and Schallreuter, 2004).
Differences in body site may also
explain the contrasting results obtained
antibodies with the same subunits (e.g.
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anti-a3, anti-b2) by different authors
(Grando et al., 1995; Kurzen et al.,
2004). Thus, human KCs express both
heteromeric and homomeric ACh-gated
ion channels, or nAChRs, and all five
known mAChR subtypes.
Classical ACh receptors are also
expressed in hair follicles and skin
adnexae (Kurzen et al., 2004). In the
outer root sheath of the hair follicle, all
ACh receptors except a9, b1, and M4
are found in the basal cell layer,
whereas a9, M4, and M5 are restricted
to the central cell layer. a5, b1, b2, and
M1–M4 are strongly expressed in the
inner root sheath. Undifferentiated se-
bocytes express a3, a9, b4, and M3–M5,
whereas a7, b2, b4, M2, and M4 are
found in mature sebocytes. In sweat
glands, the a3, a7, and M2–M5 recep-
tors are most prominent in the myo-
epithelial cells, whereas a9, b2, M1,
M3, and M4 are present in the acinar
cells. The presence of both classes of
ACh receptors in myoepithelial and
acinar cells of eccrine sweat glands
indicates a more complex regulation of
sweat production and expulsion than a
conventional dogma that ACh-induced
sweat production is under the exclusive
control of mAChRs (Kurzen and Schall-
reuter, 2004).
KC ACh uses Ca2þ as a second
messenger. A physiologic gradient of
free Ca2þ , which correlates with the
level of cell differentiation in the
epidermis (Menon et al., 1985), coin-
cides in direction with an upward
concentration gradient of free ACh
(Nguyen et al., 2001). The release of
newly synthesized ACh is coupled to
Ca2þ influx (Sastry, 1995). The nico-
tinic and muscarinic pathways of ACh
signaling in KCs exert opposing regula-
tion of transmembrane Ca2þ flux, with
nAChR mediating and mAChR inhibit-
ing Ca2þ influx and mAChR facilitating
the efflux (Grando et al., 1996; Grando
and Horton, 1997). The concentration
of intracellular free Ca2þ ([Ca2þ ]i) is
also under dual, nicotinic and muscari-
nic control. The odd- and even-num-
bered mAChRs exhibit opposing
regulation of [Ca2þ ]i in KCs, with M1
and M3 increasing and M2 and M4
decreasing the concentration of
[Ca2þ ]i (Nguyen et al., 2001). Activa-
tion of KC a7 nAChR is associated with
an increase of [Ca2þ ]i, as expected
because a7 nAChR increases [Ca2þ ]i in
other cells (Delbono et al., 1997). Thus,
the stimulatory effect of ACh on Ca2þ
influx mediated by nAChRs may be
balanced by inhibitory effects mediated
by mAChRs, and simultaneous activa-
tion of both receptors may be required
to produce a kind of a yin-yang
regulatory balance of calcium flux
and metabolism in KCs.
Simultaneous stimulation of nAChRs
and mAChRs by ACh may be required
to synchronize and balance ionic and
metabolic events in a single cell. In this
model, binding of ACh to the cell
membrane simultaneously elicits sev-
eral diverse biochemical events the
‘‘biologic sum’’ of which, taken to-
gether with cumulative effects of other
hormonal and environmental stimuli,
determines a distinct change in cell
behavior during epidermal turnover.
This plasticity of the cholinergic sys-
tems may underlie the plethoric effects
of cutaneous ACh (Table 1, and dis-
cussion below). Because KCs express a
unique combination of ACh receptor
types at each stage of their develop-
ment in the epidermis, each receptor
may regulate a specific cell function.
Hence, a single cytotransmitter, ACh,
or a cholinergic drug, may exert
differential effects on KCs at different
stages of their maturation. The muco-
cutaneous phenotypes of mice lacking
certain subtypes of ACh receptors are
shown in Table 2.
Table 1. Plethora of ACh effects on KCs is based on genetically determined changes in the repertoire of cholinergic
receptors at each stage of cell development (predominant receptor type/biological effect)
Developmental stage of KCs
Immature (basal) Transitional (prickle) Mature (‘‘keratinized’’)
Nicotinic pathways a3b2 and a3b4 a3(b2/b4)a5 a7
m Cell cycle progression m Keratinization m Cornification
m Migration m Stable cell–cell cohesion k Migration
m Unstable cell–cell cohesion
a9 a9 a9
m Cytoplasm motility m Cytoplasm motility m Apoptotic secretion
Muscarinic pathways M3 M4 M1
k Proliferation k Apoptosis m Cornification
k Migration m Migration k Migration
m Cell–substrate attachment
M4
k Apoptosis
m Migration
ACh, acetylcholine; KC, keratinocyte.
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Role of ACh in the physiologic regula-
tion of KC growth and differentiation.
KC mAChRs regulate cell cycle pro-
gression – The downstream coupling of
the mAChRs for regulation of cell cycle
progression was studied in human
gingival KCs using quantitative RT-
PCR and immunoblotting assays (Arre-
dondo et al., 2003a). Activation of KC
mAChRs upregulated expression of the
PCNA and p53 genes at both the
transcriptional and translational levels:
expression of the Ki-67 gene at the
transcriptional level and that of the p21
and cyclin D1 genes at the translational
levels only. These results indicate that
downstream signaling from mAChRs
expressed in KCs initiates complex
changes in cell cycle regulation, in-
cluding proliferation-inducing effects,
DNA repair and replication anomalies,
and proapoptotic gene activation.
Central role of a7 nAChR in KC
differentiation – The effects of functional
inactivation of a7 nAChR on KC cell
cycle progression, differentiation, and/or
apoptosis were studied in cell mono-
layers treated with a-bungarotoxin and
transfected with antisense oligonucleo-
tides and in the skin of Acra7 homo-
zygous mice lacking a7 nAChR channels
(Arredondo et al., 2002, 2003b). Elim-
ination of the a7 signaling pathway
inhibited terminal differentiation of these
cells at the transcriptional and/or transla-
tional level, and also decreased relative
amounts of the proapoptotic signaling
molecules Bad and Bax, suggesting that
a7 nAChR is coupled to stimulation of
KC apoptosis. On the other hand,
inhibition of the a7 nAChR pathway
favored cell cycle progression. In the
epidermis of a7/ mice, the abnorm-
alities in KC gene expression were
associated with phenotypic changes
characteristic of delayed epidermal turn-
over (Table 2). The skin of a7/ mice
featured decreased amounts of the ex-
tracellular matrix proteins collagen Ia1
and elastin as well as metalloproteinase
1. The a7/ KCs also demonstrated
changes in the gene expression of a3, a5,
a9, and a10 nAChR subunits, suggesting
that ACh signaling in these cells was re-
routed to alternative nicotinic pathways.
These findings indicate that ACh signal-
ing through a7 nAChR channels controls
late stages of KC development in the
epidermis by regulating expression of the
cell cycle progression, apoptosis, and
terminal differentiation genes, and that
these effects are mediated, at least in
part, by alterations in transmembrane
Ca2þ influx.
ACh is secretagogue for KC apopto-
tic secretion – The programmed cell
death of epidermal KCs culminates in
abrupt transition of granular cells into
flattened corneocytes, which is asso-
ciated with a loss in volume and dry
cell weight (Meyer et al., 1970). The
mechanism for and biological signifi-
cance of this dramatic volume loss
remain obscure. It was found that
during the granular cell–corneocyte
transition, KCs extrude into the inter-
cellular spaces of live epidermis the
cytoplasmic buds containing randomly
congregated components of the cytosol
as well as filaggrin – a precursor of the
natural moisturizing factor (Nguyen
et al., 2001). The discharge of the
secretory product was reminiscent of
both holocrine secretion and apoptotic
cell budding, suggesting the term
‘‘apoptotic secretion’’ for this novel,
essential step in the process of cornifi-
cation. A combination of a cholinergic
agonist and a muscarinic antagonist
that increases [Ca2þ ]i levels was re-
quired to trigger the apoptotic secretion
in vitro, indicating that in the epidermis
the apoptotic secretion commences
upon secretagogue action of free ACh.
Analysis of the pharmacological pro-
files of secretion regulation revealed
that the M1 mAChR and the a7 and a9
nAChRs, all of which can modulate
[Ca2þ ]i levels in KCs, work together to
Table 2. Mucocutaneous phenotypes in ACh receptor knockout mice
Knockout gene Histological findings References
Nicotinic receptor subunits
a3 The a3/ mice exhibit abnormalities of cell–cell adhesion in the stratified epithelium. The
epidermis of a3/ mice features areas of loosely attached KCs and, occasionally, prominent
clefting at the level of prickle cells
Nguyen et al. (2004b)
a7 Compared to wild-type a7+/+ mice whose epidermis usually consists of 1–2 rows of live
nucleated KCs and a compact horny layer comprised of dead corneocytes, a7/ mice aged
1–3 weeks feature thickened, multilayered epidermis consistent with retention hyperkeratosis
Arredondo et al. (2002)
Muscarinic receptor subtypes
M3 Compared to wild-type mice, 7 of 10 M3/ mice exhibited clefting in the stratified
epithelium lining the oral mucosa and/or the upper esophagus
Nguyen et al. (2004b)
One-day-old M3/ pups display accelerated hair follicle morphogenesis, as could be judged
from a significantly increased number of hair follicles in advanced stages of perinatal follicle
morphogenesis (stages 6–8) and a reciprocal decrease of the percentage of follicles at the early
stages of their development (stages 1–3), compared to wild-type controls
Chernyavsky et al. (2004b)
M4 The M4/ neonates show a retardation of hair follicle morphogenesis evidenced by a
significant increase in the number of hair follicles at the immature developmental stages and a
correspondent reduction of the percentage of hair follicles at more mature stages
Chernyavsky et al. (2004b)
ACh, acetylcholine.
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mediate an unopposed secretagogue
action of ACh at the latest stage of KC
development in the epidermis (Nguyen
et al., 2001). The essential role for a9
nAChR in the process of cornification
has been recently validated in experi-
ments with organotypic KC cultures
(Kurzen et al., 2005). In another study,
activation of a KC nAChR with nicotine
upregulated exocytosis of epidermal
lamellar bodies, indicating an impor-
tant role of the KC ACh axis in skin
permeability and barrier homeostasis
(Denda et al., 2003b).
Cholinergic regulation of KC adhesion
and motility. Cholinergic regulation of
the KC cell–cell adhesion via synergistic
pathways – Recent research demon-
strated a synergistic control of KC
adhesion through muscarinic and nico-
tinic signaling pathways mediated by
M3 mAChR, and a3 and a9 nAChRs
(Nguyen et al., 2003, 2004b). Both
muscarinic and nicotinic antagonists
cause KC detachment and reversibly
increase the permeability of KC mono-
layers to a radioactive tracer. Treatment
of human KCs with atropine increases
the phosphorylation status of desmogle-
in 3, E-cadherin, and b- and g-catenins
that contribute to the formation of
desmosomal junctions. It is known that
phosphorylation of desmogleins (Pasdar
et al., 1995; Amar et al., 1998),
desmocollin (Parrish et al., 1990), and
desmoplakin (Mueller and Franke,
1983) plays an important role in the
assembly/disassembly of cell adhesion
units. Tyrosine phosphorylation of clas-
sical cadherins disables the adherence
type junctions leading to cell–cell
detachment (Behrens et al., 1993).
Treatment with cholinergic agonists
increases the relative amounts of the
protein levels of desmoglein 1 and 3
and E-cadherin in KC cultures (Nguyen
et al., 2004a). On the other hand, long-
term blocking of a3, a9, and M3
receptor signaling pathways with anti-
sense oligonucleotides results in cell–-
cell detachment and changes in the
expression levels of E-cadherin, and
b- and g-catenins. Simultaneous inhibi-
tion of several receptor subtypes with a
mixture of antisense oligonucleotides
produces intensified abnormalities with
cell adhesion. Moreover, altered cell–-
cell adhesion is found in the stratified
epithelium of a3, a9, and M3 knockout
mice (Table 2). The KCs from these
mice exhibit abnormal expression of
adhesion molecules at both protein and
mRNA levels, indicating that the a3,
a9, and M3 ACh receptors play distinct
roles in cholinergic control of KC
adhesion. The biological significance
of this diversity may be to provide
synergistic control of KC adhesion,
allowing fine-tuning of this important
function by various exogenous and
endogenous factors activating or inhi-
biting the cholinergic receptors.
Role for a9 nAChR in the initiation
and termination of KC migration – The
first step of wound epithelialization,
that is, initiation of lateral migration,
requires from a KC to disable its stable
contacts with both the neighboring
cells, mediated by desmosomal cad-
herins, and the substrate, mediated by
‘‘sedentary’’ integrins. The second step,
that is, crawling locomotion, depends
on the ability of a KC to move over the
substrate, which involves a dynamic
process of assembly and disassembly of
the focal adhesions by ‘‘migratory’’
integrins and ‘‘linker’’ proteins. The
final step, allowing successful comple-
tion of the epithelialization process,
relies on the ability of KCs migrated
from opposite sides of the wound to
terminate migration upon collision,
forming first adherens junctions fol-
lowed by the formation of desmosomal
junctions. Current knowledge on the
role for the KC cholinergic system in
the physiologic control of epithelializa-
tion is schematically presented in
Figure 3.
Results from in vitro experiments
employing a rabbit anti-a9 antibody
demonstrated that signaling through a9
nAChRs maintains the polygonal shape
and intercellular bonds of KCs (Nguyen
et al., 2000b), playing an important
role of phosphorylation of focal adhe-
sion proteins required for normal re-
organization of integrin–cytoskeletal
interactions in a crawling cell (Schoen-
waelder and Burridge, 1999). These
results, taken together with the fact that
ligation of a9 nAChR induces phos-
phorylation of the cell membrane-
associated proteins (Szonyi et al.,
1999), predict an important role for
a9 in execution of the first and the last
steps of KC migration. Thus, a9 may
control disassembly and re-assembly of
cell–cell and cell–substrate bonds of
KCs by altering the phosphorylation
status of cadherins and sedentary
integrins, respectively (Figure 3a).
Differential regulation of KC chemo-
kinesis and chemotaxis through distinct
nAChR subtypes – Classical studies
demonstrated rapid and profound ef-
fects of nicotinic and muscarinic drugs
on the velocity of crawling locomotion,
and cell–substrate and cell–cell adhe-
sion of KCs (reviewed by Grando,
1997). Most recently, ACh-coupled
signaling pathways regulating KC chemo-
kinesis and chemotaxis were stu-
died using respective modifications of
the agarose gel KC outgrowth system
(Chernyavsky et al., 2004a). Random
migration (chemokinesis) was signifi-
cantly inhibited by the a-conotoxins
MII and AuIB preferentially blocking
a3-containing nAChRs, whereas the a7
nAChR blocker a-bungarotoxin upre-
gulated chemokinesis. The use of
nAChR subunit-selective antisense oli-
gonucleotides and knockout mice de-
monstrated a pivotal role for a3b2
channel in mediating ACh-dependent
chemokinesis, and revealed an inhibi-
tory role of a7. Signaling pathways
downstream of a3b2 included activa-
tion of the PKC isoform d, as well as
RhoA-dependent events (Figure 3a).
The nicotinic chemotaxis of KCs was
most pronounced toward the concen-
tration gradient of choline, a potent
agonist of a7 nAChR (Alkondon et al.,
1997). a-Bungarotoxin significantly di-
minished KC chemotaxis, further sug-
gesting a central role for a7 nAChR
(Chernyavsky et al., 2004a). This hypo-
thesis was confirmed in experiments
with anti-a7 oligonucleotides, and KCs
from a7 knockout mice. The signaling
pathway mediating a7-dependent KC
chemotaxis included [Ca2þ ]i, activation
of calcium/calmodulin-dependent pro-
tein kinase II, conventional isoforms of
PKC, phosphatidylinositol-3-kinase, and
recruitment of Rac/Cdc42 (Figure 3a).
Synergistic effects of nAChRs and
mAChRs on regulation of KC direc-
tional migration – Galvanotropism in a
direct current electric field represents a
natural model of cell re-orientation
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toward the direction for future migra-
tion. It was abrogated owing to inhibi-
tion of ACh production by
hemicholinium-3 and restored by the
exogenously added mixed nicotinic-
and-muscarinic agonist carbachol
(Chernyavsky et al., 2005). These re-
sults indicated that KC galvanotaxis (ie
cathodal migration) is in fact chemo-
taxis toward a concentration gradient
of ACh or choline, which are created in
a direct current field owing to their
highly positive charge, as demonstrated
by HPLC measurements. A time-course
immunofluorescence study of the
membrane redistribution of ACh recep-
tors in KCs exposed to a direct current
field revealed rapid relocation to and
clustering at the leading edge of a7
nicotinic and M1 muscarinic receptors.
Inactivation of each receptor with
selective antagonists or small interfer-
ing RNA (siRNA) decreased galvano-
tropism, which could be partially
prevented by transfecting the cells with
constitutively active mitogen-activated
protein kinase kinase (MEK)1. The
pharmacologic and molecular modi-
fiers of the Ras/Raf-1/MEK1/extracellu-
lar signal-regulated kinase (ERK)
signaling pathway altered both galva-
notropism toward the cathode and
chemotaxis toward choline in a similar
way, indicating that the same signaling
steps are involved. The end-point effect
of the cooperative signaling down-
stream from a7 and M1 through
MEK1/ERK is an upregulated expression
of the sedentary a2 and a3 integrins, as
judged from the results of real-time
PCR and quantitative immunoblotting.
Perhaps, simultaneous signaling down-
stream from a7 and M1 activates the
Ras/Raf-1/MEK1/ERK pathway at the
leading edge of a KC. This compart-
mentalized event may be required for
stabilization of the lamellipodium ow-
ing to its stable adherence to a substrate
via the sedentary integrins (Figure 3a
and b).
Reciprocal regulation of KC direc-
tional migration through M3 and M4
mAChRs – The agarose gel KC out-
growth system was used to discern
contributions of individual mAChR
subtypes to cholinergic regulation of
KC motility (Chernyavsky et al., 2003,
2004b). siRNA-M4 significantly de-
creased and siRNA-M3 increased ran-
dom migration distances of KCs. The
enhanced migration of the siRNA-M3-
transfected KCs could be inhibited
when the cells were fed with the M4-
preferring antagonist MT3. Conversely,
the inhibition of migration of the
siRNA-M4-transfected KCs could be
prevented in the presence of 4-dipheny-
lacetoxy-N-methylpiperidine methiodide
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Figure 3. Hypothetical schemes of stimulatory (-) and inhibitory (B) events within the nicotinic (a)
and the muscarinic (b) signaling cascades mediating the cholinergic control of KC migration. The
downstream signaling from the muscarinic and nicotinic classes of ACh receptors involves the second
messenger pathways that control expression and activity of the effector molecules mediating crawling
locomotion of KCs and wound epithelialization. Whereas a9 nAChR is primarily involved in the
regulation of assembly and disassembly of cell–cell contacts and focal adhesions, the M3/M4 and a3/a7
receptor pairs exhibit reciprocal control of the integrin expression patterns. AC, adenylyl cyclase; AR,
adrenergic receptor; [Ca2þ ]i, intracellular free calcium; CaMKII, Ca
2þ /calmodulin-dependent protein
kinase II; cAMP, cyclic AMP; cGMP, cyclic GMP; ERK, extracellular signal-regulated kinase; GC,
guanylyl cyclase; MEK, mitogen-activated protein kinase kinase; PI3K, phosphatidylinositol-3-kinase;
PKA, protein kinase A; PKC, protein kinase C; PKG, protein kinase G; ROK, Rho-associated protein
kinase.
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(4-DAMP), which blocks M3 receptors
(but also other mAChR subtypes) with
high affinity. The lack of M3 receptors in
KCs grown from the epidermis of M3/
mice was associated with an increase of
migration distance by approximately
85%. The M4/ KCs showed a re-
duced migration distance by 450%.
MT3 significantly decreased the migra-
tion distances of M3/ KCs, whereas 4-
DAMP increased the migration distance
of M4/ KCs. These results indicate
that M3 and M4 have opposing roles in
the regulation of KC random migration.
To elucidate the mechanisms of
regulatory effects of M3 and M4 on KC
migration, we pharmacologically
blocked, or activated, key steps of the
signaling pathways known to mediate
functions of the Gq/11 (i.e., M3)- and Gi/o
(i.e., M4)-coupled mAChRs (Chernyavs-
ky et al., 2004b). Inhibition of migration
by M3 was mediated by the Ca
2þ -
dependent guanylyl cyclase/cGMP/pro-
tein kinase G signaling pathway. The
M4 effects resulted from inhibition of
the adenylyl cyclase/cAMP/protein ki-
nase A pathway. Both signaling path-
ways intersected at Rho, indicating that
Rho kinase provides a common effector
for the M3 and M4 pathways regulating
KC migration (Figure 3b).
Relevance to wound epithelializa-
tion – The concentration of cholinergic
molecules is altered by wounding
(Kishimoto et al., 1982). The exogen-
ous ACh and carbachol as well as some
selective muscarinic and nicotinic ago-
nists can facilitate epithelial wound
healing in laboratory animals (Wester-
man et al., 1993; Er, 1997; Ozturk
et al., 1999). The physiologic relevance
of cholinergic control of epithelializa-
tion was investigated using a murine
model of skin wound healing (Cher-
nyavsky et al., 2004b). Excisional
wounds, 1 cm2, were inflicted in the
back skin of M3/, M4/, and wild-
type mice. The morphometric analysis
revealed that on the 5th day, the
epithelization rate in M3/ mice
was increased by B60%, and that in
M4/ mice was decreased byB50%,
indicating that the early stage of wound
epithelialization, mediated by KC mi-
gration (Woodley et al., 1993), was
facilitated in the absence of M3 and
delayed in the absence of M4. Quanti-
tative analysis of mRNAs and proteins
demonstrated that in M3/ mice, the
relative expression levels of the seden-
tary integrins a2 and a3 were decreased
in both intact and wounded skin,
whereas those of ‘‘migratory’’ integrins
a5, av, and b5 were increased. In M4/
mice, the relative amounts of sedentary
integrins were significantly increased in
the intact skin. This suggested that
silencing of M3 favors the expression
of the migratory integrins, whereas
silencing of M4 upregulates the seden-
tary integrins (Figure 3b).
Cholinergic control of MCs
The cholinergic system of skin MCs.
Early studies have suggested the pre-
sence of classic ACh receptors in
human pigment-producing cells (Kohn
et al., 1996). These results were con-
firmed and further elaborated in re-
cently completed studies aimed at the
molecular characterization and immu-
nolocalization of mAChRs (Buchli
et al., 2001) and nAChRs (Buchli
et al., 1999) in normal human MCs.
Cultured MCs were found to express
the M1–M5 subtypes of mAChRs on
their cell membrane. The RT-PCR
experiments also revealed mRNA tran-
scripts of a1, a3, a5, a7, b1, b2, g, and d
nAChR subunits in human MCs. The
PCR products were further character-
ized by restriction analysis, and the
results were verified in another set of
experiments, using anti-mAChR and
anti-nAChR antibodies corresponding
to the ACh receptor types amplified in
PCR experiments.
Stimulation of MCs with micromolar
concentrations of carbachol or muscar-
ine induced a peak of [Ca2þ ]i in MCs,
reaching approximately 10 times the
baseline at 100mM of muscarine (Buchli
et al., 2001). The rise of [Ca2þ ]i could
be blocked with atropine but not with
mecamylamine, suggesting that a gang-
lionic nAChR subtype was not in-
volved. Regulation of [Ca2þ ]i through
MC ACh receptors suggests an impor-
tant physiologic role of the ACh axis in
MC behavior and skin pigmentation.
Indeed, in cultures of human MCs, ACh
increases the quantity of Bcl-2 and
other cell proteins and decreases TH
and DOPA oxidase activities (Zhao
et al., 1996).
Cholinergic regulation of tegumental
pigmentation. In certain plants, prokar-
yotes, and eukaryotes, light modulates
ACh metabolism, and ACh mediates
biologic effects of light on the organism
(Tretyn and Kendrick, 1991; Gupta
et al., 1997). ACh mediates the re-
sponse to light at all major physiologic
levels. At the level of retinal photo-
receptor, amacrine cells release ACh in
response to light stimulus (Masland and
Livingstone, 1976), which conveys the
signal to the central nervous system. At
the level of pituitary melanotrophs,
ACh stimulates melanotrope cells to
produce a-MSH (Lamacz et al., 1989),
which conveys the message to the skin.
At the skin level, ACh inhibits the local
response of MCs to a-MSH (Moller and
Lerner, 1966), and directly alters vital
functions of MCs. Although the source
of ACh regulating tegumental color is
yet to be identified, it may not be
limited to the nervous system (Hanlon
et al., 1990). In the skin of lower
vertebrates, ACh has been shown to
induce pigment redistribution (Hayashi
and Fujii, 1994) and melanosome
movement (Ovais, 1994). The disper-
sion of melanin granules within MCs is
associated with a high rate of melano-
genesis and release of melanin granules
for an intercellular transport, whereas
the aggregation of melanin granules is
associated with a lower rate of mela-
nogenesis and little or no intercellular
transport (Goldman and Hadley, 1968).
Acting through its nicotinic recep-
tors, ACh has been shown to elicit
pigmentation. Melanin pigmentation
was the predominant finding in oral
mucosal lesions at the site of applica-
tion for 3–6 months of a sublingual
tablet containing 2 mg nicotine in a
smoking cessation study (Wallstrom
et al., 1999). Nicotine was more potent
than ACh in inducing melanosome
dispersion in dermal MCs (melano-
phores) of a teleostean fish (Visconti
et al., 1984), and the a7 agonist choline
produced a pigment-dispersing effect in
fish melanophores (Oshima et al.,
1992).
The nicotinic effects of ACh, leading
to hyperpigmentation, seem to be con-
trolled by its muscarinic effects,
mediated by mAChRs. The mAChRs
were implicated in mediating neurally
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evoked pigment aggregation in glass
catfish melanophores (Fujii et al.,
1982). In the frog skin bioassays, ACh
produced the skin lightening effect,
which was inhibited completely by
atropine (Moller and Lerner, 1966).
On the other hand, selective blockade
of mAChRs with atropine or other
muscarinic antagonists, which directs
the signaling of endogenous ACh to MC
nAChRs, caused a potent pigment-
dispersing effect (Nagaishi et al.,
1992). These results suggest that activa-
tion of mAChRs inhibits melanogen-
esis. Kurzen and Schallreuter (2004)
have recently proposed that the MC M2
and M4 subtypes, which are known to
inhibit cAMP synthesis, produce a
negative feedback on tyrosinasepig-
mentation to counteract the a-MSH/
melanocortin-1 receptor and catecho-
lamine/b2-adrenergic response in MCs,
as described by Gillbro et al. (2004).
CHOLINERGIC SYSTEM OF IMMUNE
COMPETENT CELLS FOUND IN THE
EPIDERMIS
Kawashima and Fujii (2004) proposed
that ACh may play an intermediary role
in the dialogue between immune com-
petent and tissue cells regulating the
immune function and local circulation.
Whereas the Langerhans cells residing
in follicular and interfollicular epider-
mis were demonstrated to express AChE
(Hollis and Lyne, 1972; Townsend
et al., 1997), all known components of
the cholinergic system, such as high-
affinity choline transporter, ChAT, vesi-
cular ACh transporter, AChE, mAChRs,
and nAChRs, have been found in
lymphocytes (reviewed by Kawashima
and Fujii, 2004). By RT-PCR, Northern
blot analyses, and immunocytochem-
ical techniques, M3, M4, and M5
mAChRs were identified in almost all
human peripheral blood lymphocytes
tested, whereas expression of M1 and
M2 mAChRs varied among different
subjects (Sato et al., 1999). Tayebati
et al. (2002) reported that M3 is the
most strongly expressed subtype, fol-
lowed in order by M5, M4, and M2. This
is in agreement with the results of
radioligand binding experiments, show-
ing that the relative density of lympho-
cyte mAChRs is M34M54M44M2
(Ricci et al., 2002). The nAChRs in
human circulating lymphocytes may
consist of subunits a2, a4, a7, a9, a10,
b2, and b4 (Benhammou et al., 2000;
Lustig et al., 2001), whereas the
nAChRs expressed in human thymo-
cytes may contain the a3, a4, and a5
subunits (Mihovilovic et al., 1997).
Thus, ACh released from KCs may play
a role in regulating the function of
immune competent cells residing in or
infiltrating the epidermis, which, in
turn, can act on KCs and MCs by
altering the concentration of free epi-
dermal ACh.
CLINICAL SIGNIFICANCE OF THE
EPIDERMAL CHOLINERGIC NET-
WORK
Mal de Meleda
Mal de Meleda is a rare autosomal
recessive palmoplantar keratoderma
that shows biochemical features of
hyperproliferative epithelium (Sybert
et al., 1988). Mutations in the ARS B
gene (EMBL AC: X99977) were found
to underlie this disease (Fischer et al.,
2001; Mastrangeli et al., 2003). The
ARS B gene encodes a polypeptide
belonging to the Ly-6/CD59/uPAR (ur-
okinase-type plasminogen activator re-
ceptor)/snake toxin superfamily termed
SLURP-1 (secreted mammalian Ly-6/
uPAR-related protein-1). The amino-
acid composition of SLURP-1 is homo-
logous to that of the single-domain frog
cytotoxin and snake venom neurotox-
ins, such as a-bungarotoxin (Fischer
et al., 2001). Chimienti et al. (2003)
examined ACh-elicited macroscopic
current responses in control and
SLURP-1-treated Xenopus oocytes ex-
pressing recombinant human a7
nAChRs. SLURP-1 enhanced the am-
plitude of the ACh-evoked macro-
scopic currents in a concentration-
dependent manner. It was concluded
that SLURP-1 modulates nAChR func-
tion in the presence of its natural ligand
ACh, consistent with an allosteric
mode of action. Since in macrophages
ACh had been shown to inhibit TNF-a
release through a7 nAChR (Wang et al.,
2003), it was proposed that SLURP-1
controls TNF-a release in both macro-
phages and KCs through a7 nAChR,
and that inactivation of this pathway
leads to cutaneous inflammation in Mal
de Meleda (Chimienti et al., 2003).
We cloned human SLURP-1 and
produced recombinant protein and the
monoclonal antibody 336H12-1A3
that visualized native SLURP-1 (Arre-
dondo et al., 2005b). SLURP-1 ligated
the conventional ligand binding site of
KC nAChRs, showing a higher affinity
to the [3H]nicotine-sensitive nAChRs,
compared to the [3H]epibatidine-sensi-
tive nAChRs, and significantly in-
creased the activities of caspases 3
and 8, and the number of TUNEL-
positive cells. These results suggest that
the biological role of SLURP-1 in
the epidermis is to provide fine-tuning
of the physiologic regulation of
KC functions through the cholinergic
pathways.
Psoriasis
When Tsuji et al. (2003) performed
microarray analysis of gene expression
in skin samples of patients with psor-
iasis, they identified expressed se-
quence tags whose expression was
predominantly increased in the af-
fected skin. Among them, the authors
discovered a novel member of the Ly-6
superfamily that they termed SLURP-2.
The SLURP-2 protein displays 28–34%
amino-acid identity with most mem-
bers of the Ly-6 superfamily, and is
found in multiple cell and tissue types,
mainly in KCs, but not in spleen or
bone marrow. By real-time PCR, the
SLURP-2 expression in the psoriatic
lesions was found to be upregulated
3.8- and 2.8-fold compared with that in
the normal skin and the psoriatic
nonlesional skin, respectively (Tsuji
et al., 2003). SLURP-2 is also upregu-
lated in KCs grown in culture. Radi-
oligand binding inhibition experiments
showed that SLURP-2 can bind to the
conventional ligand binding sites of KC
nAChRs (Arredondo et al., 2005a).
SLURP-2 has a high affinity to [3H]epi-
batidine-sensitive nAChRs. In real-time
PCR experiments, preincubation of KCs
with SLURP-2 inhibited caspase 3 and
filaggrin by 410- and 412-fold, re-
spectively. These results suggest that
the biological role of SLURP-2 in the
epidermis is also related to a fine-
tuning of the physiological regulation
of KC functions by ACh. SLURP-2 may
be involved in the pathophysiology of
psoriasis through its role in KC hyper-
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proliferation and/or T-cell differentia-
tion/activation (Tsuji et al., 2003).
Atopic dermatitis
Although it was known for a long time
that ACh levels are elevated in the
lesional skin of patients with atopic
dermatitis, the assumption was that
ACh originated from sensory nerves
(Scott, 1962). Recent experimental evi-
dence indicates that non-neuronal ACh
is involved in the pathogenesis of atopic
dermatitis (Wessler et al., 2003). In skin
biopsies from atopic dermatitis patients,
ACh is increased 14-fold in the super-
ficial epidermis and upper dermis and
three-fold in the underlying deeper
dermis and hypodermis. The pathophy-
siologic role of ACh may be related to
its ability to cause itch, vasodilatation,
and a wheal and flare reaction (Heyer
and Rukwied, 1996; Heyer et al., 1997;
Rukwied and Heyer, 1998, 1999). The
mechanism responsible for upregulated
ACh levels in the atopic skin remains to
be elucidated.
Vitiligo
The response of MCs to ACh depends
on the activity/amount of the ACh-
degrading enzyme AChE. The AChE
activity is lowered in vitiliginous skin
during depigmentation, but returns to
normal on repigmentation (Iyengar,
1989), in keeping with the delayed
‘‘local clearing’’ of ACh hypothesis of
vitiligo (Chanco-Turner and Lerner,
1965). Only very recently it has been
recognized that AChE, but not ChAT,
activity is regulated by H2O2 (Schall-
reuter et al., 2004). A kinetic analysis
using pure recombinant human AChE
revealed that low concentrations of
H2O2 (10
6
M) activate this enzyme by
increasing the Vmax by 42-fold, mean-
while high concentrations of H2O2
(103 M) inhibit the enzyme with a
significant decrease in Vmax. Molecular
modeling based on the established 3D
structure of human AChE demonstrated
that H2O2-mediated oxidation of
Trp(432), Trp(435), and Met(436)
moves and disorients the active site
His(440) of the enzyme, leading to
deactivation of the protein (Schallreuter
et al., 2004). Considering that the outer
layer of human skin can be a target for
UV-generated H2O2 in the millimolar
range, this mechanism needs to be
taken into account for the regulation
of ACh homeostasis in skin biology and
pathology. In this context, it has been
suggested that ACh, as well as milli-
molar concentrations of H2O2, may
well account for the described pruritus
in active/progressive vitiligo (Elwary
et al., unpublished results, 2004;
Kurzen and Schallreuter, 2004).
Patients with vitiligo also have a
decreased sweating response in both
their lesional and non-lesional skin
compared with healthy age- and sex-
matched controls after stimulation with
the ACh agonist pilocarpine (Elwary
et al., 1997). The decreased cholinergic
response of the dermal sweat glands in
this patient group correlates with a
significantly lower Ca2þ concentration
in sweat compared with controls. In
addition, a significantly higher Kþ
concentration was found in the pig-
mented skin of these patients, whereas
the other fast exchange ions Naþ and
Cl were unaffected.
Pemphigus
In addition to autoantibodies against
desmogleins, patients with pemphigus
have also been found to have anti-
AChR receptor antibodies (reviewed by
Grando, 2000). These non-desmoglein
antibodies can induce pemphigus-like
lesions in neonatal mice, suggesting
that they may play a role in the
pathogenesis of pemphigus vulgaris
Nguyen et al., 1998; Nguyen et al.,
2000c). We have proposed a multiple
hit hypothesis that reconciles the
presence of both anti-AChR and
anti-desmoglein antibodies. This hy-
pothesis proposes that acantholysis
(i.e., cell–cell detachment of KCs) in
pemphigus results from a synergistic
and cumulative effect of autoantibodies
targeting KC cell membrane antigens of
different kinds, including (i) molecules
that regulate cell shape and adhesion
(e.g., ACh receptors) and (ii) molecules
that mediate cell-to-cell adhesion (e.g.,
desmosomal cadherins). In this hypoth-
esis, the severity of the disease and the
exact clinical picture would depend on
the ratio of different kinds of autoanti-
bodies. Further studies addressing this
hypothesis will further our understand-
ing of the pathogenesis of pemphigus.
Palmoplantar pustulosis
This dermatosis is thought to represent
an autoimmune disease with anti-mus-
cle-type nAChR binding skin structures
precipitated by smoking (Hagforsen
et al., 2002a). Abnormalities in the
expression of ChAT and AChE were
detected in the epidermis of lesional
skin of patients with palmoplantar
pustulosis, being most pronounced in
the sweat gland apparatus (Hagforsen
et al., 2000). In a separate study, the a3
and a7 nAChR expression in the palmar
skin of patients with palmoplantar
pustulosis was compared with that in
healthy smoking and non-smoking
controls by immunohistochemistry
with a monoclonal anti-a3 and a
polyclonal anti-a7 antibody (Hagforsen
et al., 2002). Epidermal a3 staining was
stronger and that of the coil and dermal
ducts weaker in healthy smokers than
in healthy non-smokers. The normal
epidermal a7 staining pattern was
abolished in patients’ skin and was
replaced by strong mesh-like surface
staining, most markedly adjacent to the
acrosyringium, which in controls was
intensely a7 positive at this level. It was
concluded that smoking (nicotine) can
influence nAChR expression in the
skin, and that the non-neuronal choli-
nergic system may be involved in
cutaneous inflammatory processes.
TREATMENT
Pyridostigmine bromide (Mestinon),
which produces cholinomimetic effects
due to both inhibition of ACh degrada-
tion by AChE and binding to nAChRs
(Akaike et al., 1984; Taylor, 1985), has
been shown to ameliorate pemphigus
acantholysis via a mechanism that
upregulates expression and function of
KC adhesion molecules (Nguyen et al.,
2004a). These findings justified both a
clinical trail of systemic Mestinon treat-
ment of pemphigus patients (Grando,
2004) and the use of a solution of the
muscarinic agonist pilocarpine for topi-
cal treatment of pemphigus erosions
(Namazi, 2004). In a double-blind,
placebo-controlled study, skin erosions
of patients with pemphigus vulgaris
were treated for 15 days with either
4% pilocarpine or placebo gel (Iraji and
Yoosefi, 2005). The epithelialization
index was 40.371.7 in skin lesions
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treated with pilocarpine, compared to
24.473.3 (Po0.001) in patients treated
with placebo.
Anecdotal reports in the literature
document significant improvement of
the mucocutaneous disease in patients
who received cholinergic agents as a
part of their treatment for a concurrent
medical condition or owing to habitual
use of nicotine products. These condi-
tions include pyoderma gangrenosum
(Kanekura and Kanzaki, 1995), malig-
nant atrophic pustulosis (Kanekura
et al., 2003), orogenital ulcerations
(Kanekura and Kanzaki, 1999), lichen
planus (Kuwahara et al., 2000), pem-
phigus (Mehta and Martin, 2000),
psoriasis (Gajewski, 1970), Kimura’s
disease, and erythema nodosum (Kane-
kura et al., 2004). Furthermore, the
traditional remedy for eczema in Ban-
gladesh contains high amounts of
nicotine (Davies et al., 2001). In a
randomized clinical study, a facial gel
containing 3% of the cholinergic agent
2-dimethylaminoethanol (deanol) ap-
plied daily for 16 weeks has been
shown to be safe and efficacious in
the mitigation of forehead lines and
periorbital fine wrinkles, and in im-
proving lip shape and fullness and the
overall appearance of aging skin
(Grossman, 2005).
The above reports suggest that cho-
linergic agents have a huge potential
for dermatological use. Since at differ-
ent stages of their development, skin
cells express unique combinations of
ACh receptors, a receptor-specific drug
will be able to selectively alter vital
functions of the cells expressing mainly
this ACh receptor type. Thus, learning
cholinergic pharmacology of skin cell
functions together with the availability
of receptor-selective drugs can offer
novel specific and effective dermato-
logic treatments without hazardous
side effects. Hence, drugs simulta-
neously altering several signaling path-
ways, such as glucocorticoids, can be
avoided by using agents acting on a
single signaling pathway.
ADRENERGIC AND CHOLINERGIC
SECOND MESSENGERS AND SIGNAL
PATHWAYS IN THE EPIDERMIS
The adrenergic and cholinergic ligan-
d–receptor families expressed in the
epidermis are capable of transducing
a multiplicity of signals into the cyto-
plasm and nucleus of KCs and MCs.
The intricately regulated and highly
communicative signaling systems of
these epidermal cells have evolved into
a complex and finely coordinated net-
work of second messenger and intra-
cellular signaling pathways (Figure 4).
These interconnected communication
pathways maintain basal homeostatic
control within the epidermis as well as
induce a myriad of compensatory
responses required of the epidermis to
serve a broad range of functions,
including barrier protection, control of
pigmentation, cell replenishment, and
wound healing.
Many of the classical intracellular
second messenger systems have been
identified in the epidermis that func-
tionally link extracellular and intracel-
lular compartments, thereby mediating
signal transduction for the catechola-
mine-adrenergic and ACh-cholinergic
receptor systems reviewed herein. The
adenylyl cyclase and guanylyl cyclase
families of membrane and soluble
signal transducers have emerged as
pivotal enzymes linking these receptors
to intracellular second messengers (Su-
nahara and Taussig, 2002; Pyriochou
and Papapetropoulos, 2005). Early
investigations in dermatology had fo-
cused on psoriasis and perturbations in
cAMP and cGMP as mediators of
epidermal hyperproliferation and dis-
ease pathogenesis (Voorhees and
Duell, 1971). Similar early works sug-
gested that the adrenergic receptor and
cAMP were major signaling compo-
nents of pigmentation in amphibian
skin (Novales and Davis, 1967;
McGuire, 1970). The concept of a
microenvironment (microdomain)
within the cell to further localize
(target) and regionally regulate cAMP
expression and downstream activation
has recently been suggested. Oscilla-
tions in cAMP, related to calcium
feedback may play relevant roles in
dynamic biological activities mediated
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Figure 4. The crosstalk between the adrenergic and cholinergic signaling pathways is mediated by
stimulatory (-) and inhibitory (B) effects of common second messengers. The intracellular second
messenger pathways involved include the cAMP- and cGMP-coupled responses, calcium, protein kinases
A, C, and G, phosphatidylinositol-3-kinase, phospholipase C, and various downstream mitogen-activated
protein kinases as well as less well-defined second messenger transducers that transduce receptor-
activating events at the cell surface of epidermal cells to the nucleus or other intracellular targets, the
‘‘net sum’’ of which determines the biological response. AC, adenylyl cyclase; AR, adrenergic receptor;
[Ca2þ ]i, intracellular free calcium; cAMP, cyclic AMP; DAG, diacylglycerol; ERK, extracellular
signal-regulated kinase; IP3, inositol-3-phosphate; MAPK, mitogen-activated protein kinase; nAChR,
nicotinic acetylcholine receptor channel; PI3K, phosphatidylinositol-3-kinase; PLC, phospholipase;
PKA, protein kinase A; PKC, protein kinase C; SR, sarcoplasmic reticulum.
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by adrenergic and cholinergic signaling
events (reviewed in Cooper, 2003;
Tasken and Aandahl, 2004).
The remarkable expansion of our
knowledge base over the past 40 years
has led to a more comprehensive
understanding of the adenylyl and
guanylyl cyclases and the superfamily
of G-protein-coupled receptors. These
discoveries have provided a more
detailed view of how adrenergic and
cholinergic receptors mediate signaling
responses in epidermal cells (Grando,
1997; Schallreuter, 1997b; Sunahara
and Taussig, 2002; Grando et al., 2003;
Pyriochou and Papapetropoulos,
2005). Additional intracellular signal-
ing pathways involving protein kinases
A, C, and G, phosphatidylinositol-3-
kinase, phospholipase C, calcium/cal-
modulin, and various downstream mi-
togen-activated protein kinases have
been shown to play significant roles
in adrenergic- and cholinergic-
mediated responses in KCs and MCs,
as outlined in Figure 4.
Both the adrenergic and muscarinic
cholinergic receptors belong to the G-
protein-coupled receptor superfamily.
However, other receptor-coupled sig-
naling pathways intersect and modu-
late the functions mediated by these
specific pathways, such as the a-MSH/
melanocortin-1 receptor pathway, an-
other G-protein coupled receptor fa-
mily member also involved in MC
signaling and pigmentation (Rouzaud
et al., 2005). The adrenergic and
muscarinic receptor pathways, as have
been reviewed herein, appear to inter-
act in KCs and MCs to counterbalance
both stimulatory and inhibitory signals
for regulation of vital cell functions.
Additional well-characterized second
messengers and signaling pathways
have been shown to transmit adrener-
gic and cholinergic receptor activation
events to various intracellular targets,
including the nucleus and various
cytoplasmic and organelle termination
sites. They have been reviewed briefly
in the previous sections, but the range
of pathways, the mechanisms of trans-
duction, receipt and localization of
signal events, and complexities of
dynamic biological responses are be-
yond the scope of this review. Taken
together, it is clear that both the
adrenergic and cholinergic signals form
a special symbiotic axis between epi-
dermal KCs and MCs.
PERSPECTIVES
The adrenergic and cholinergic systems
in the skin are integral pathways that
form a major component of the cuta-
neous communication network. Cate-
cholamines and ACh are small
molecule ligands, unlike peptides and
polypeptides, and have the ability to be
rapidly synthesized and degraded, as
well as regulated by anatomical char-
acteristics of the skin, age, and endo-
crine and environmental stimuli.
Unique combinations of these factors
in a particular study object may be
responsible for the variability in pub-
lications on the structure and functions
of the adrenergic and cholinergic sys-
tems from different laboratories. Most
of the results obtained on these im-
portant signaling pathways have been
obtained in vitro using cell cultures of
KCs and MCs, and are also subject to
regulation by culture media. Future
investigations will be needed to fully
elucidate how the adrenergic and
cholinergic systems, with their ligands
and receptors, are integrated. It is
obvious that the epidermis in situ is
exposed constantly to intrinsic and
extrinsic challenges from UV light,
temperature, hormones, growth factors,
and fluctuating second messengers,
such as cAMP and Ca2þ . Therefore,
before broad clinical interventions with
adrenergic and cholinergic agonists/
antagonists can be undertaken, we
need more information on the respon-
siveness of the epidermis in vivo.
Hence, further research needs to be
undertaken on how adrenergic and
cholinergic ligands and receptors con-
trol the physiologic functions in a
variety of skin diseases.
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